The Digital Reality Check: New white paper

Digital ambition is high in pharma, but execution still lags.

We spoke to 100 senior leaders across life sciences, with additional expert commentary from Pfizer, Grünenthal, Chiesi and more, to uncover what’s really driving progress - and what’s getting in the way.

From AI adoption to omnichannel reality, CRM choices to compliance hurdles, this report reveals where pharma stands on digital maturity in 2025.

If you’re shaping strategy, you’ll want these insights.

Get your copy below.